(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 482 KiB)
Idle, J.R.; Seipel, K.; Bacher, U.; Pabst, T.; Beyoğlu, D. (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers 2020, 12, 2842. https://doi.org/10.3390/cancers12102842
Idle JR, Seipel K, Bacher U, Pabst T, Beyoğlu D. (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers. 2020; 12(10):2842. https://doi.org/10.3390/cancers12102842
Chicago/Turabian StyleIdle, Jeffrey R.; Seipel, Katja; Bacher, Ulrike; Pabst, Thomas; Beyoğlu, Diren. 2020. "(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia" Cancers 12, no. 10: 2842. https://doi.org/10.3390/cancers12102842